Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous platelet-rich plasma for cartilage regeneration in osteoarthritic chondrocytes
NL-OMON32313Active, not recruiting
- Sponsor
- Catharina Ziekenhuis
- Start
- Sep 2008
- Modality
- Adoptive Cell Transfer → Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous platelet-rich plasma and autologous thrombin in osteoarthritis (OA), sponsored by Catharina Ziekenhuis. Primary endpoints: Cell proliferation, Extracellular matrix production and 1 more. Started Sep 2008; status: active, not recruiting.
02
Drugs
autologous platelet-rich plasmaautologous thrombin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON32313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32313.